AR056082A1 - Formas cristalinas de clorhidrato de irinotecano (monoclorhidrato de 7-etil-10-[4-(1-piperidin)-1-piperidin]carboniloxicamptotecina trihidratado) y metodos de preparacion de las mismas - Google Patents

Formas cristalinas de clorhidrato de irinotecano (monoclorhidrato de 7-etil-10-[4-(1-piperidin)-1-piperidin]carboniloxicamptotecina trihidratado) y metodos de preparacion de las mismas

Info

Publication number
AR056082A1
AR056082A1 ARP060104123A ARP060104123A AR056082A1 AR 056082 A1 AR056082 A1 AR 056082A1 AR P060104123 A ARP060104123 A AR P060104123A AR P060104123 A ARP060104123 A AR P060104123A AR 056082 A1 AR056082 A1 AR 056082A1
Authority
AR
Argentina
Prior art keywords
crystalline form
irinotecan hydrochloride
hydrochloric acid
piperidin
ethanol
Prior art date
Application number
ARP060104123A
Other languages
English (en)
Spanish (es)
Inventor
Shu-Ping Chen
Piin-Jye Harn
Original Assignee
Scinopharm Singapore Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Singapore Pte Ltd filed Critical Scinopharm Singapore Pte Ltd
Publication of AR056082A1 publication Critical patent/AR056082A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP060104123A 2005-09-20 2006-09-21 Formas cristalinas de clorhidrato de irinotecano (monoclorhidrato de 7-etil-10-[4-(1-piperidin)-1-piperidin]carboniloxicamptotecina trihidratado) y metodos de preparacion de las mismas AR056082A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71882705P 2005-09-20 2005-09-20

Publications (1)

Publication Number Publication Date
AR056082A1 true AR056082A1 (es) 2007-09-19

Family

ID=37889452

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104123A AR056082A1 (es) 2005-09-20 2006-09-21 Formas cristalinas de clorhidrato de irinotecano (monoclorhidrato de 7-etil-10-[4-(1-piperidin)-1-piperidin]carboniloxicamptotecina trihidratado) y metodos de preparacion de las mismas

Country Status (14)

Country Link
US (1) US7435818B2 (https=)
EP (2) EP2082741A1 (https=)
JP (1) JP5119153B2 (https=)
KR (1) KR101150504B1 (https=)
CN (1) CN101277694B (https=)
AR (1) AR056082A1 (https=)
AT (1) ATE460162T1 (https=)
AU (1) AU2006292328B2 (https=)
BR (1) BRPI0616308A2 (https=)
CA (1) CA2623117C (https=)
DE (1) DE602006012871D1 (https=)
ES (1) ES2343204T3 (https=)
NZ (1) NZ566807A (https=)
WO (1) WO2007035709A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101318964B (zh) * 2007-06-07 2010-12-15 上海迪赛诺医药发展有限公司 盐酸伊立替康新晶型及其制备方法
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
IT1391757B1 (it) * 2008-11-11 2012-01-27 Antibioticos Spa Irinotecan cloridrato cristallino e metodi per la sua preparazione
US8546573B2 (en) 2009-11-18 2013-10-01 Cadila Healthcare Limited Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate
WO2012007952A1 (en) * 2010-07-12 2012-01-19 Hetero Research Foundation Novel polymorph of irinotecan hydrochloride
CN102311443B (zh) * 2011-08-24 2014-07-16 上海北卡医药技术有限公司 盐酸伊立替康的新晶型及其制备方法
CN102617584B (zh) * 2012-03-14 2013-10-16 海南锦瑞制药股份有限公司 一种盐酸伊立替康化合物及其药物组合物
CN102850363B (zh) * 2012-09-18 2013-07-10 山东罗欣药业股份有限公司 盐酸伊立替康化合物及其药物组合物
MX2015014486A (es) * 2013-04-15 2016-07-21 Regeneron Pharma Marcadores de respuesta de células tumorales a la terapia.
CN105713004A (zh) * 2016-03-23 2016-06-29 杭州华东医药集团新药研究院有限公司 一种高品质盐酸伊立替康三水合物晶型的制备方法
US10919905B2 (en) * 2019-05-16 2021-02-16 Scinopharm Taiwan, Ltd. Polymorphism for irinotecan free base

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
AR015190A1 (es) * 1997-10-23 2001-04-18 Smithkline Beecham Corp Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento
EP1248869A2 (en) 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
JP2005525367A (ja) 2002-03-01 2005-08-25 フアルマシア・イタリア・エツセ・ピー・アー 塩酸イリノテカンの結晶多形
CZ20022250A3 (cs) * 2002-06-27 2004-02-18 Pliva-Lachema A. S. Způsob výroby irinotekanu
NZ541990A (en) 2003-02-25 2009-04-30 Yakult Honsha Kk Method for preparing polymorphism of irinotecan hydrochloride
JP2008509211A (ja) * 2004-08-09 2008-03-27 シルパ・メディケア・リミテッド 塩酸イリノテカン三水和物の改良された製造方法
US20060046993A1 (en) * 2004-09-01 2006-03-02 Pharmacia Italia S.P.A. Crystalline polymorphic form of irinotecan hydrochloride
WO2006082279A1 (en) * 2005-02-07 2006-08-10 Fermion Oy Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin
PL1928883T3 (pl) * 2005-02-08 2014-03-31 Fermion Oy Sposób otrzymywania chlorowodorku irynotekanu

Also Published As

Publication number Publication date
AU2006292328B2 (en) 2012-12-20
US7435818B2 (en) 2008-10-14
CN101277694B (zh) 2011-04-20
EP1951235A4 (en) 2008-10-29
ES2343204T3 (es) 2010-07-26
JP2009508874A (ja) 2009-03-05
AU2006292328A1 (en) 2007-03-29
CA2623117A1 (en) 2007-03-29
EP1951235B1 (en) 2010-03-10
EP1951235A2 (en) 2008-08-06
WO2007035709A2 (en) 2007-03-29
ATE460162T1 (de) 2010-03-15
KR20080059244A (ko) 2008-06-26
NZ566807A (en) 2011-05-27
DE602006012871D1 (de) 2010-04-22
KR101150504B1 (ko) 2012-07-09
CA2623117C (en) 2013-12-10
EP2082741A1 (en) 2009-07-29
CN101277694A (zh) 2008-10-01
JP5119153B2 (ja) 2013-01-16
WO2007035709A3 (en) 2007-10-25
US20070072890A1 (en) 2007-03-29
BRPI0616308A2 (pt) 2011-06-14

Similar Documents

Publication Publication Date Title
AR129907A2 (es) FORMA CRISTALINA DEL HEMIHIDRATO DE 1-(b-D-GLUCOPIRANOSIL)-4-METIL-3-[5-(4-FLUOROFENIL)-2-TIENILMETIL]BENCENO, COMPOSICIÓN FARMACÉUTICA, PROCESO PARA LA PREPARACIÓN Y USOS
AR056082A1 (es) Formas cristalinas de clorhidrato de irinotecano (monoclorhidrato de 7-etil-10-[4-(1-piperidin)-1-piperidin]carboniloxicamptotecina trihidratado) y metodos de preparacion de las mismas
AR063347A1 (es) Formas cristalinas de docetaxel y proceso para su preparacion
WO2007048066A3 (en) Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
JP2011126894A5 (https=)
BRPI0817154A2 (pt) "método de modificar uma célula de levedura para a produção de etanol, célula de levedura modificada, uso de uma célula de levedura modificada e método para a produção de etanol"
PH12014500673A1 (en) Method for producing glufosinate p free acid
SI1598333T1 (sl) Postopek za pripravo (1s)-4,5-dimetoksi-1-(metilaminometil)-benzociklobutana in njegovih adicijskih soli, kot tudi uporaba za sintezo ivabradina in njegovih adicijskih soli s farmacevtsko sprejemljivo kislino
GEP20115343B (en) New method for preparing functionalised benzocyclo-butenes and its application to the synthesis of ivabradine and its addition salts with a pharmaceutically acceptable acid
BRPI0518647A2 (pt) processo para a produÇço de um composto, e, composto
BRPI0413393A (pt) fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina
UA105425C2 (ru) Кристаллическая форма агомелатина гидрохлорида гидрата и способ ее получения
AR048527A1 (es) Variedades cristalinas de acetato de bazedoxifeno
RU2013149168A (ru) Аналоги эпоксиэйкозатриеновой кислоты и способы их получения и использования
CN103864760B (zh) 一种盐酸法舒地尔化合物
DE602007012924D1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
WO2008099286A3 (en) Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
WO2008146284A3 (en) Crystalline rotigotine base and preparation process therefor
CN101979376B (zh) 甘氨酰胺盐酸盐的制备方法
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
WO2009084039A8 (en) Process for producing 1-[2-(dimethylamino)-1-(4-phenol)ethyl]cyclohexanol
ECSP088153A (es) Nuevos derivados de piperidina
CN102977039B (zh) 6-氟-3-羟基-2-吡嗪甲酰胺α晶型及其制备方法
CN107827819A (zh) 一种喷他佐辛晶型及其制备方法

Legal Events

Date Code Title Description
FB Suspension of granting procedure